There is one big reason that minerals are extremely important. If certain minerals are deficient in your body then those genes that fight cancer are not activated.
Selenium is one such mineral that is necessary to activate certain genes to help you suppress the formation of cancer cells. Here is what selenium does in your body to fight cancer and improve your immune system.
China’s fastest-growing automaker, GAC Motor, has released two new SUVs onto the market, the 5-seat GS7 and the entry SUV GS3 in watertown Wuzhen, Zhejiang Province, China where tradition embraces innovation. These two next-generation SUVs, which have inherited the excellent genes of the GAC Motor family, are poised to bolster the company’s already astounding growth and drive its plans for global expansion.
GAC Motor chose Wuzhen as the place to begin its redefinition of SUVs for young consumers because of the water town’s rich history, its status as a hotbed for high-tech and innovation, and because of its youthful, fashionable and forward-thinking vibes, which is in line with the targeted young consumers of the two new models. Since 2014, Wuzhen has been the home for the World Internet Conference, which attracts prominent internet figures from 120 countries.
To view the multimedia release go to:
https://www.multivu.com/players/English/8166551-gac-motor-gs7-gs3-launch/
23andMe, working in collaboration with the Milken Institute and Lundbeck, today announced that they have commenced enrollment for a first-of-its kind genetic study designed to gain understanding of the underlying biology of major depressive and bipolar disorders. This study will combine cognitive assessments with genetic data and survey responses to assess how genes influence brain processes – such as attention, decision-making and visual perception – in individuals who live with these serious mental health conditions.
“We know genetics play a role in the development of depression and bipolar, however there is a long pathway from our genes to the manifestation of complex diseases like these,” said Emily Drabant Conley, PhD., Vice President of Business Development at 23andMe. “We need to look at these conditions in a more comprehensive way to advance our understanding. By studying cognitive function alongside genetics and other environmental variables on a massive scale, we hope to take a significant step forward in the study of depression and bipolar.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8150951-23andme-genetic-study-depression-bipolar-disorders/
El pasado domingo 5 de junio, El Dasa, protagonista de la exitosa serie “El Vato”, ofreció un concierto gratuito en Universal CityWalk™ presentado por NBC UNIVERSO donde fans de todas las edades acudieron a ver a su ídolo. El popular locutor de la Súper Estrella 107.1 FM, Eddie “Piolín” Sotelo, estuvo a cargo de la conducción y de presentar al talentoso y carismático cantante de Hermosillo, Sonora. Para descargar imágenes de los mejores momentos del concierto de El Dasa haga clic aquí y para ver el video, ingrese aquí.
El Dasa arrancó el concierto cantando “Perdí el Sombrero”, el tema principal de “El Vato”, la serie original de NBC UNIVERSO creada para el mercado hispano en Estados Unidos. Luego le siguió con “Alegre y Enamorado”, un tema que rinde tributo a todos los estados de México y donde la emoción de los asistentes se sintió cada vez que se mencionaba su estado natal. Pero el ambiente se prendió cuando el Dasa empezó a bailar con sus movimientos sensuales de cadera al cantar “Mentirosa”. La canción que desató gritos efusivos fue cuando El Dasa dedicó a todas las damitas “Por ser Bonita”. Aparte de cantar sus éxitos y otras clásicas canciones de banda, los asistentes tuvieron la primicia de escuchar “Ya me vi”, el primer sencillo de su nuevo material discográfico que saldrá a la venta este verano.
To view the multimedia release go to:
http://www.multivu.com/players/Spanish/7609253-nbc-universo-el-vato-citywalk/
BloodCenter of Wisconsin’s Diagnostic Laboratories today announced the availability of a comprehensive cancer mutation HemeOnc Panel using next generation sequencing (NGS) technology. The NGS panel developed by BloodCenter of Wisconsin is designed to detect variants in 30 genes that are either prognostic or diagnostic for 10 different myeloid hematologic malignancies.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7363151-bloodcenter-of-wisconsin-launches-next-generation-sequencing-hemeonc-panel/
El satélite DEIMOS-2, el primero español de muy alta resolución puesto en órbita el pasado 19 de junio, ha comenzado a captar sus primeras imágenes tan solo 12 horas de entrar en operación.
DEIMOS-2, lanzado desde la base de lanzamiento de Yasny (Rusia), ha sido desarrollado en un tiempo récord de tres años por Elecnor Deimos. Para la integración y posterior control de la misión DEIMOS-2, la compañía ha creado un innovador Centro de Integración y Operaciones de Satélites en Puertollano (España), completando así su presencia en toda la cadena de valor de las misiones espaciales.
Para ver el Multimedia News Release, vaya a http://www.multivu.com/mnr/71400573-elecnor-deimos-2-satellite-images
Lluvia de sangre, imágenes que lloran, personas que manifiestan los estigmas de Jesús en su cuerpo… la profunda devoción popular encuentra una explicación a estos hechos: son milagros que expresan un mensaje divino. Pero, ¿qué pasa si estos acontecimientos se examinan científicamente? En su nueva producción original, Discovery en Español viaja por distintos países de América Latina y analiza 16 eventos reales en busca de la verdad. MISTERIOS DE LA FE se transmitirá los jueves a las 9PM E/P, a partir del 13 de junio.
Para más, visite http://www.multivu.com/mnr/61953-discovery-en-espanol-investigative-series-misterios-de-la-fe-june-13
Researchers studying the genetic roots of the most common malignant childhood brain tumor have discovered missteps in three of the four subtypes of the cancer that involve genes already targeted for drug development.
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
Weight loss is perhaps the most common New Year’s resolution made and likely the most difficult to keep. Amway North America offers the NUTRILITE® Weight Management Program, which includes a genetic test that helps individuals find their genotype-matched diet, and offers weight management plans matched to that gene test’s results.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53285-amway-nutrilite-weight-management-program-new-year-resolutions-julie-upton
The bold and thrilling quest to finally understand the brain—and along with it our mental afflictions, from depression to autism—by a rising star in neuroscience
Sebastian Seung, a dynamic young professor at MIT, is at the forefront of a revolution in neuroscience. He believes that our identity lies not in our genes, but in the connections between our brain cells—our own particular wiring. Seung and a dedicated group of researchers are leading the effort to map these connections, neuron by neuron, synapse by synapse. It is a monumental effort—the scientific equivalent of climbing Mount Everest—but if they succeed, they will uncover the basis of personality, identity, intelligence, memory, and perhaps disorders such as autism and schizophrenia. Seung explains how this new map of a human “connectome” might even enable us to “upload” our brains into a computer, making us effectively immortal.
Connectome is a mind-bending adventure story, told with great passion and authority. It presents a daring scientific and technological vision for at last understanding what makes us who we are, both as individuals and as a species. Find out more here, http://bit.ly/yEBoyq Non-Fiction
On October 21st, 2011, Lancôme invites customers to experience the “Beauty of Giving” by celebrating Genes Day, a one-day national event Lancôme began in 2010 to support St. Jude Children’s Research Hospital, one of the world’s premier centers for the research and treatment of pediatric cancer and other catastrophic childhood diseases. On this day, Lancôme will donate $7 from the sale of every bottle of Génifique Youth Activating Concentrate to St. Jude. (This is in addition to special promotions and events nationwide surrounding Genes Day throughout the month of October.)
To view Multimedia News Release, go to http://www.multivu.com/mnr/52300-lancome-genes-day-2011-st-jude-julia-roberts-genifique-beauty-of-giving
